CTLA-4Ig在诱导器官移植免疫耐受中的研究新进展
被引量:2
摘要
目前器官移植最大障碍依然是术后排斥反应的发生。因此,寻找诱导免疫耐受的方法一直是器官移植领域的研究热点。抗原特异性T细胞的有效活化除需要TCR识别抗原提呈细胞(antigen presenting cell,APC)提呈的MHC一肽作为第一信号外,还必需有APC和T细胞表面的共刺激分子之间相互作用所提供的共刺激信号作为第二信号才能顺利完成,阻断该第二信号而仅有第一信号则可以引起T细胞克隆无能甚至是凋亡,从而诱导器官移植免疫耐受。
出处
《中华内分泌外科杂志》
CAS
2012年第1期57-58,共2页
Chinese Journal of Endocrine Surgery
基金
国家自然科学基金(30871295)
参考文献18
-
1Buhlmann JE, Elkin SK, Sharpe AH. A role for the B7-1/B7-2:CD28/CTLA-4 pathway during negative selection[ J]. J Immunol, 2003,170( 11 ) : 5421-5428.
-
2Wang Y, Ni Y, Wei H, et al. Stable skln-specific overexpression of human CTLA4-Ig in transgenic mice through seven generations [ J ]. Acta Biochim Biopys Sin, 2006,38 ( 3 ) : 171 - 178.
-
3胡明道,赵恋峰,于恒海,唐继红,黄明,刘峰,周玉凯,李立.CTLA4-Ig融合蛋白诱导猕猴同种异体肝移植免疫耐受的实验研究[J].中国普外基础与临床杂志,2010,17(1):40-45. 被引量:2
-
4Jin YZ, Zhang QX, Xie SS. Low-dose donor bone marrow cells and splenocytes plus adenovirus encoding for CTLA-4Ig gene promote stable mixed chimerism and long-term survival of rat cardiac allografts [ J ]. Transplant Proc,2003,35 (4) :3156-3159.
-
5Gilson CR, Milas Z, Gangappa S, et al. Anti-CD40 monoelonal antibody synergizes with CTLA4-Ig in promoting long-term graft survival in murine models of transplantation[ J]. J Immunol,2009, 183(3) :1625-1635.
-
6Emamaullee JA, Davis J, Pawlick R, et al. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice[ J]. Diabetes,2008, 57(6) :1556-1566.
-
7Emamaullee JA, Davis J, Pawlick R, et al. Caspase inhibitor therapy synergizes with costimulation blockade to promote indefinite islet allograft survival [ J ]. Diabetes ,2010,59 ( 6 ) : 1469-1477.
-
8Botturi K, Lacoeuille Y, Thomas P, et al. CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients [ J ]. Eur Respit J ,2008,31 (6) :1167-1176.
-
9Hoff H, Knieke K, Cabail Z, et al. Surface CD152(CTLA-4) expression and signaling dictates longevity of CD28null T cells[J]. J Immunol,2009,182(9) :5342-5351.
-
10Yue D, Brintnell W, Mannik LA, et al. CTLA-4Ig blocks the development and progression of citrullinated fibrinogen-induced arthritis in DR4-transgenic mice [J]. Arthritis Rheum, 2010, 62 (10) :2941-2952.
二级参考文献14
-
1Lu, Sen,Yu, Yue,Gao, Yun,Li, Guo-Qiang,Wang, Xue-Hao.Immunological inhibition of transplanted liver allografts by adeno-associated virus vector encoding CTLA4Ig in rats[J].Hepatobiliary & Pancreatic Diseases International,2008,7(3):258-263. 被引量:10
-
2Guo-Ping Jiang, Zhen-Hua Hu, Shu-Sen Zheng, Chang-Ku Jia, Ai-Bin Zhang, Wei-Lin Wang, Department of Hepatobiliary Pancreatic Surgery, Key Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou 310003, Zhejiang Province, China.Adenovirus-mediated CTLA4Ig gene inhibits infiltration of immune cells and cell apoptosis in rats after liver transplantation[J].World Journal of Gastroenterology,2005,11(7):1065-1069. 被引量:14
-
3唐映梅,何晓顺,陈规划,陈旻湖.肝移植术后早期肝功能的动态变化及其对预后的价值[J].中华内科杂志,2005,44(4):268-271. 被引量:18
-
4Smith RM, Mandel TE. Pancreatic islet xenotransplantion: the polential for tolerance induction . Immunol Today, 2000,21(1):42-48.
-
5Judge TA,Tang A,Spain LM,et al.The in vivo mechanism oh action of CTLA4Ig .J Immunolog,1 1996, 156(6):2294-229.
-
6Hutloff A, Diltrieh AM, Beier KC, et al. ICOS is an inducible T cell co-stimulalor structurally and functionally related to CD28.Nature,1999,379(6716):263-266.
-
7Yoshinaga SK,Whoriskey JS,Khare SD,et al.T-cell costimulation through B7RP-1 and ICOS.Nature,1999,402(6763):827-832.
-
8Dong C,Jueds AE,Temann UA,et al.ICOS co-stimulatory receptor is essential or T-cel activation and function.Nature,2001,409(6816):97-101.
-
9Tafuri A,Shahinian A,Bladt F,et al.ICOS is essential for effective T-helper-cell responses.Nature,2001,409(6816):105-109.
-
10CAO Hui LIU Hua WU Zhi-yong.Effects of combined immune therapy on survival and Th1/Th2 cytokine balance in rat orthotopic liver transplantation[J].Chinese Medical Journal,2007(20):1809-1812. 被引量:11
同被引文献12
-
1Ramin Sabahi,Dr Jennifer H.Anolik.B-cell-targeted therapy for systemic lupus erythematosus[J].Drugs,2006,66(15):1933-1948.
-
2Judith Leitnera,Katharina Grabmeier-Pfistershammerb,Peter Stein-bergera.Receptors and ligands implicated in human T cell costimulatory processes[J].Immunol Lett,2010,128(2):89-97.
-
3Ben-Shoshan,Moshe.CTLA-4Ig:uses and future directions[J].Recent Pat Inflamm Allergy Drug Discov,2009,3(2):132-142.
-
4Merrill JT,Burgos-Vargas R,Westhovens R,et al.The efficacy andsafety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus:Results of a twelve-month,multicenter,exploratory,phase IIb,randomized,double-blind,placebo-controlled trial[J].Arthritis Rheum,2010,62(10):3077-3087.
-
5Bonelli M,Femer E,Gschl L,et al.Abatacept(CTLA-4IG)treatment reduces the migratory capacity of monocytes in patientswith rheumatoid arthritis[J].Arthritis Hheum,2013,65(5):599-607.
-
6Bert Verbinnen,An D.Billiau,Jan Vermeiren,et al.Contribution oiregulatory T cells and effector T cell deletion in toleranceinduction by costimulation blockade[J].J Immunol,2008,181(2):1034-1042.
-
7Rudd CE,Alison Taylor,Helga Schneider.CD28 and CTLA4 coreceptor expression and signal transduction[J].Immunol Rev,2009,229(1):12-26.
-
8Menghua Zeng,Elisabeth Guinet,Mahyar Nouri-Shirazi.B7-1 and B7-2 differentially control peripheral homeostasis of CD4+ CD25 +Foxp3+ regulatory T cells[J].Transpl Immunol,2009,20(3):171-179.
-
9高增燕,邱玉华,谢芳,顾永平,杨天杰,黄莉,杨晓惠,施勤.B7-1抗体阻断B7/CD28信号通路对Pristane肾病的治疗作用[J].中国免疫学杂志,2010,26(10):927-931. 被引量:2
-
10陈永芬,韩波,伊迎春,张仪,路康,孙士静.CTLA-4Ig融合蛋白对病毒性心肌炎小鼠Foxp3+调节性T细胞的影响[J].临床儿科杂志,2011,29(7):665-669. 被引量:5
引证文献2
-
1王芳,黄翠丽,林有坤,罗彦彦,温斯健,刘慧,黄小耿.CTLA-4Ig对B6.MRL-Faslpr/J狼疮小鼠脾脏Th17和Treg细胞表达的影响与其对小鼠狼疮样病征干预作用的相关性研究[J].中国免疫学杂志,2015,31(1):40-44. 被引量:1
-
2徐安琪,杨晓帆,王慧娟,张缪佳,季晓辉.系统性红斑狼疮患者外周血T细胞CTLA-4表达及其临床意义[J].南京医科大学学报(自然科学版),2017,37(1):62-68. 被引量:3
二级引证文献4
-
1汪美奂,黄瑾,马君鑫,徐思琪,沈敏宁,陈兴国,苏定雷,顾冰洁,王小琴,杨磊磊,任启洁,王林农.系统性红斑狼疮患者角膜神经纤维和干眼临床研究[J].南京医科大学学报(自然科学版),2020,40(8):1222-1225. 被引量:3
-
2侯刘进,赵红川.器官移植免疫耐受的研究进展及临床应用[J].肝胆外科杂志,2016,24(3):231-233. 被引量:1
-
3胡安印,梁淼,罗舒艳,窦环.CTLA-4与自身免疫性疾病的研究进展[J].医学综述,2018,24(16):3121-3126. 被引量:7
-
4向莉平,钱颐森,杨楚楚,陈昱宁,尤书慧,冯振卿,张茜.IgG在CpG DNA诱导巨噬细胞活化与JNK和p38通路中的作用[J].南京医科大学学报(自然科学版),2019,39(8):1112-1117. 被引量:4
-
1孙运鹏,张启瑜,沈志坚.T细胞共刺激信号诱导器官移植免疫耐受的研究进展[J].国际外科学杂志,2007,34(8):532-536. 被引量:1
-
2孙治君.诱导器官移植免疫耐受研究进展[J].重庆医科大学学报,2000,25(3):330-333.
-
3蔡勇,刘玉兰.间充质干细胞的免疫学特性及其诱导器官移植免疫耐受的前景[J].中华器官移植杂志,2008,29(3):190-191.
-
4张治国,殷晓玲.同源造血干细胞输注诱导器官移植免疫耐受的研究进展[J].国外医学(移植与血液净化分册),2003,1(2):43-45.
-
5罗晓军,赵海霞,贾富全.免疫抑制剂在角膜移植术后排斥反应中的应用[J].疾病监测与控制,2010,4(12):699-700.
-
6陆炯炯,杜隽铭,周学平,杨勇,李济宇,全志伟.大鼠原位肝移植术后排斥反应病理动态变化[J].上海交通大学学报(医学版),2007,27(4):475-477. 被引量:12
-
7张磊,胡江.肝脏移植免疫耐受的研究进展[J].包头医学院学报,2006,22(1):112-114.
-
8樊斌,李德卫.树突状细胞与肝移植免疫耐受[J].中华内分泌外科杂志,2010,4(5):347-348.
-
9李鹏,胡明道.共刺激通路与同种异体器官移植免疫耐受[J].新医学,2011,42(9):625-627.
-
10崔晓,刘冠贤,石咏军.建立嵌合体诱导移植免疫耐受的研究进展[J].当代医学,2008,14(14):25-26. 被引量:1